QWM
VKTX icon

Quadcap Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Quadcap Wealth Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-700
Closed -$16.9K – 416
2025
Q1 		$16.9K Buy
700
+200
+40% +$6.32K ﹤0.01% 375
2024
Q4 		$20.1K Buy
+500
New +$28.5K ﹤0.01% 378
2024
Q3 		– Sell
-100
Closed -$5.3K – 407
2024
Q2 		$5.3K Buy
+100
New +$6.55K ﹤0.01% 382

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quadcap Wealth Management's VKTX Position: Q2 2026 in Review

Quadcap Wealth Management opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 5,758 shares worth $225K. The stake represents 0.02% of the portfolio and ranks #383 among its holdings. This is a return to the name: Quadcap Wealth Management previously reported a position in VKTX as recently as Q3 2025.

Quadcap Wealth Management first reported a position in VKTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $629K in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Quadcap Wealth Management held 5,758 shares of Viking Therapeutics worth $225K as of Q2 2026.
  • Viking Therapeutics was a new Quadcap Wealth Management position in Q2 2026.
  • Viking Therapeutics made up 0.02% of Quadcap Wealth Management's portfolio in Q2 2026, its #383 holding.
  • Quadcap Wealth Management first reported a position in Viking Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • Quadcap Wealth Management's Viking Therapeutics position peaked at $629K in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.